BHC-34 |
A |
09:00 AM - 09:10 AM |
CLINICAL PROFILE AND TREATMENT OUTCOMES OF INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH HAEMATOLOGICAL DISEASES - A TERTIARY CARE CENTER EXPERIENCE |
NAVEEN VAIRAMOORTHY |
BHC-35 |
A |
09:10 AM - 09:20 AM |
MANAGEMENT OF BREAKTHROUGH BLEEDING EPISODES IN THE PHASE 3 CONCIZUMAB STUDIES |
ABY ABRAHAM |
BHC-36 |
A |
09:20 AM - 09:30 AM |
PLASMA EMICIZUMAB LEVELS, CLOTTING TIME BY ROTATIONAL THROMBOELASTOMETRY AND CLINICAL BLEEDS IN HAEMOPHILIA PATIENTS ON STANDARD AND LOW DOSE EMICIZUMAB PROPHYLAXIS. |
RUCHA PATIL |
BHC-37 |
A |
09:30 AM - 09:40 AM |
UTILIZING SCREENING ASSAY RESULTS TO PREDICT BETHESDA INHIBITOR TITRES IN PATIENTS WITH HEMOPHILIA A: A COST EFFECTIVE STRATEGY |
NANDHINI GANGADARAN |
BHC-39 |
A |
09:40 AM - 09:50 AM |
HARNESSING MONOCYTE DISTRIBUTION WIDTH: A GAME-CHANGER IN EARLY SEPSIS IDENTIFICATION IN ADULT INTENSIVE CARE |
AYUSHI RAGHUVANSHI |
BHC-44 |
A |
09:50 AM - 10:00 AM |
ACUTE PAIN MANAGEMENT STRATEGIES IN SICKLE CELL ANAEMIA: A TWO-YEAR COMPARATIVE STUDY OF ADULT AND PAEDIATRIC EMERGENCY VISITS |
KOLLI SAI KRISHNA |
BHL-23 |
B |
09:00 AM - 09:10 AM |
ANTIPHOSPHATIDYLSERINE/PROTHROMBIN (APS/PT) IGG: A SURROGATE MARKER FOR LUPUS ANTICOAGULANT? |
HIMIL PARIKH |
BHL-24 |
B |
09:10 AM - 09:20 AM |
HBA1C THROUGH CAPILLARY ELECTROPHORESIS, AS A TOOL TO RECOGNIZE HEMOLYTIC ANEMIAS AND HEMOGLOBINOPATHIES |
PRADEEP KUMAR V |
BHL-25 |
B |
09:20 AM - 09:30 AM |
BAMBO: EMPOWERING SEGMENTATION WITH AN ANNOTATED BONE MARROW BIOPSY DATASET |
HEM SUNDER THIRUMURTHY |
BHL-26 |
B |
09:30 AM - 09:40 AM |
SIGNIFICANCE OF EMERGING INFLAMMATORY HAEMATOLOGICAL RATIOS AND DISTRIBUTION WIDTHS IN TYPE 2 DIABETES MELLITUS. |
SONAM SHARMA |
BHL-27 |
B |
09:40 AM - 09:50 AM |
DETECTION OF CIRCULATING TUMOUR CELLS IN THE BLOOD USING EPCAM AND CYTOKERATIN IN COLORECTAL CARCINOMA BY FLOWCYTOMETRY. |
SUDHANSHU SULANIA |
BHL-29 |
B |
09:50 AM - 10:00 AM |
EXPRESSION OF CD45RO AND CD45RA BY FLOWCYTOMETRY IN PAEDIATRIC PRIMARY IMMUNODEFICIENCY CASE AND ITS CORRELATION WITH MOLECULAR PATHWAYS USING RAG1 AND TREC GENES |
MOHIT KUMAR |
MHC-21 |
C |
09:00 AM - 09:10 AM |
EXPLORING TREATMENT-FREE REMISSION IN CML: A SINGLE INSTITUTE EXPERIENCE |
SHIVANI RANGA |
MHC-22 |
C |
09:10 AM - 09:20 AM |
COMPARISON OF DASATINIB 70 MG/DAY VERSUS 100 MG/DAY IN NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA [CML-CP]: A SINGLE-CENTER, RANDOMISED CONTROL STUDY |
PARAS SATADEVE |
MHC-23 |
C |
09:20 AM - 09:30 AM |
TREATMENT OUTCOMES OF PEDIATRIC & AYA PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS USING UPFRONT GENERIC DASATINIB & AUGMENTED ALL IC-BFM 2009 CHEMOTHERAPY PROTOCOL: A SINGLE-CENTER STUDY |
ADAMYA GUPTA |
MHC-24 |
C |
09:30 AM - 09:40 AM |
TRANSCRIPT PROFILING AND ITS IMPACT ON SURVIVAL IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) PATIENTS |
ANAND HOSALLI |
MHC-31 |
C |
09:40 AM - 09:50 AM |
A RETROSPECTIVE STUDY OF LIGHT CHAIN AMYLOIDOSIS IN THE CURRENT ERA: A TERTIARY CARE CENTER EXPERIENCE FROM NORTHERN INDIA |
NITIN GUPTA |
MHC-32 |
C |
09:50 AM - 10:00 AM |
VENETOCLAX IN TREATMENT OF REFRACTORY ETP-ALL: A SINGLE CENTER EXPERIENCE |
NAMAN BANSAL |
MHL-13 |
D |
09:00 AM - 09:10 AM |
MRD ANALYSIS BY MOLECULAR METHOD (DDPCR)VS FLOWCYTOMETRY IN ACUTE MYELOID LEUKEMIA WITH RECURRENT CYTOGENETIC ABNORMALITIES. |
MANASVI SHAH |
MHL-14 |
D |
09:10 AM - 09:20 AM |
MANTLE CELL LYMPHOMA - CLINICOPATHOLOGICAL PROFILE AT A TERTIARY CANCER CENTRE |
RAVI TEJA JULOORI |
MHL-15 |
D |
09:20 AM - 09:30 AM |
UTILITY OF KIR MARKERS IN ESTABLISHING CLONALITY IN MATURE NK CELL LYMPHOMAS BY FLOW CYTOMETRY |
PRERONA ROY |
MHL-16 |
D |
09:30 AM - 09:40 AM |
A COMPREHENSIVE CLINICAL,FLOWCYTOMETRIC & MOLECULAR MUTATIONAL ANALYSIS AND DISCUSSION OF VARIANT TRANSLOCATIONS OF ACUTE PROMYELOCYTIC LEUKEMIA (APL): AN EXPERIENCE FROM TERTIARY HOSPITAL. |
PRAMOD KUMAR PAMU |
MHL-17 |
D |
09:40 AM - 09:50 AM |
PRACTICAL VALUE OF CD48 IN T-ACUTE LYMPHOBLASTIC LEUKEMIA MRD- USING 13-COLOR MULTI PARAMETRIC FLOW CYTOMETRY. |
SANJOLI CHUGH |
MHL-18 |
D |
09:50 AM - 10:00 AM |
IMMUNOPHENOTYPIC CHARACTERIZATION OF NORMAL HEMATOPOIETIC STEM CELLS USING 16-COLOR MULTIPARAMETRIC FLOW CYTOMETRY(MFC). |
SANJOLI CHUGH |
BHC-15 |
E |
09:00 AM - 09:08 AM |
IRON OVERLOAD-RELATED PANCYTOPENIA IN BETA THALASSEMIA TRAIT: A RARE CLINICAL PRESENTATION |
SATYAKI MANDAL |
BHC-16 |
E |
09:08 AM - 09:16 AM |
UNMASKING HLH IN TROPICAL INFECTION: A CASE SERIES FROM AN INDIAN TERTIARY CARE CENTER |
SATYAKI MANDAL |
BHC-17 |
E |
09:16 AM - 09:24 AM |
PROCALCITONIN IS SUPERIOR TO CRP IN PREDICTING BACTERAEMIA AND MORTALITY IN NEUTROPENIC FEVER IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES. |
NAVEEN VAIRAMOORTHY |
BHC-18 |
E |
09:24 AM - 09:32 AM |
A RETROSPECTIVE ANALYSIS OF HEMOGLOBINOPATHY PATTERN & DISTRIBUTION IN A NEW TERTIARY CARE HOSPITAL OF WEST BENGAL USING CE-HPLC |
SUDHANSHU SHEKHAR |
BHC-19 |
E |
09:32 AM - 09:40 AM |
LOW VOLUME THERAPEUTIC PLASMA EXCHANGE (0.5 PLASMA VOLUME) IN PATIENT WITH RAT POISONING (RATOL 3% YELLOW PHOSPHORUS) WITH MULTI-ORGAN INVOLVEMENT- A CASE REPORT |
PINJARI CHINIGI SAB |
BHC-21 |
E |
09:40 AM - 09:48 AM |
ONE STONE, TWO BIRDS: THERAPEUTIC PLASMA EXCHANGE FOR MANAGEMENT OF HYPERVISCOSITY AND PREVENTION OF RITUXIMAB RELATED IGM FLARE IN WALDENSTROM'S MACROGLOBINEMIA |
JUILEE CHARMODE |
BHC-22 |
E |
09:48 AM - 09:56 AM |
A TALE OF TWO ANTIBODIES: MIXED AIHA: A CASE REPORT |
AISHWARYA V |
BHC-23 |
E |
09:56 AM - 10:04 AM |
TRANSFORMING SICKLE CELL TREATMENT: THE IMPACT OF ERTHROCYTAPHERESIS ON PATIENT OUTCOMES |
JUILEE CHARMODE |
BHC-24 |
E |
10:04 AM - 10:12 AM |
COMPARATIVE ANALYSIS OF APHERESIS VERSUS POOLED BUFFY COAT GRANULOCYTES : A CASE-BASED REVIEW. |
AISHWARYA V |
BHC-26 |
E |
10:12 AM - 10:20 AM |
DIAGNOSTIC CHALLENGES IN A CASE OF RARE BLEEDING DISORDER |
SAVITRI SINGH |
BHC-28 |
E |
10:20 AM - 10:28 AM |
DESIGN AND OPERATION OF A GOOD MANUFACTURING PRACTICES (GMP) LABORATORY IN INDIA |
RIZWAN JAVED |
MHC-10 |
E |
10:28 AM - 10:36 AM |
CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA AGED ? 40 YEARS : EXPERIENCE FROM A TERTIARY CARE CANCER CENTRE IN INDIA |
GEORGE JOHN |
BHC-29 |
E |
12:30 PM - 12:38 PM |
USE OF ARTIFICIAL INTELLIGENCE TO GUIDE UNTRAINED INDIVIDUALS PERFORMING SELF-ULTRASOUND SCANS OF THE KNEE JOINT |
MUZAMMIL KHAN PATHAN |
BHC-31 |
E |
12:38 PM - 12:46 PM |
BLOOD GROUP DISCREPANCY IN AIHA COMPLICATED BY SLE: A DIAGNOSTIC CHALLENGE |
ADITYA RANE |
BHC-32 |
E |
12:46 PM - 12:54 PM |
CASE OF CHRONIC COUGH AND INTERSTITIAL LUNG DISEASE WITH NEUTROPENIA: A DIAGNOSTIC CHALLENGE |
BHAIRAVABHATLA V S P VISWANADH |
BHC-33 |
E |
12:54 PM - 01:02 PM |
CLINICAL PROFILE OF CHILDREN OF CHRONIC IMMUNE THROMBOCYTOPENIA (ITP): A SINGLE CENTRE RETROSPECTIVE STUDY |
SAUMYA JAIN |
BHC-38 |
E |
01:02 PM - 01:10 PM |
IS BONE MARROW EXAMINATION NEEDED FOR DIAGNOSIS OF IMMUNE THROMBOCYTOPENIA |
NAGARJUN SAI JAINE |
BHC-41 |
E |
01:10 PM -01:18 PM |
PLATELET PARAMETERS AND RED CELL TRANSFUSIONS IN PATIENTS OF POSTPARTUM HEMORRHAGE |
VAISHALI SHARMA |
BHC-42 |
E |
01:18 PM - 01:26 PM |
HEMOGLOBIN E HEMOGLOBINOPATHY, THE SILENT EPIDEMIC: AN INSTITUTIONAL EXPERIENCE FROM KALYANI. |
SUJAYA MAZUMDER |
BHC-43 |
E |
01:26 PM - 01:34 PM |
"SHROUDED IN MYSTERY: THE LINCOLN LOG VERTEBRA'S SILENT SIGNAL IN SICKLE CELL DISEASE" |
AMIT TURKAR |
BHC-45 |
E |
01:34 PM - 01:42 PM |
COMPARISON OF D-DIMER TO FIBRINOGEN RATIO (DFR) WITH DOPPLER ULTRASONOGRAPHY IN EVALUATION OF SUSPECTED DEEP VENOUS THROMBOSIS |
SADHANASHREE MUTHUSAMI |
BHC-47 |
E |
01:42 PM - 01: 50 PM |
BEHIND THE PALE AND BEYOND THE RED- A CASE SERIES ON PURE RED CELL APLASIA |
KALAIVANAN B |
MHC-2 |
E |
01:50 PM - 01:58 PM |
CLINICAL PROFILE AND OUTCOMES OF HAIRY CELL LEUKEMIA FROM TWO CENTERS IN INDIA: A CALL FOR COLLABORATIVE RESEARCH |
SUVIR SINGH |
MH-1 |
E |
01:58 AM - 02:06 AM |
MOLECULAR LANDSCAPE OF PRECURSOR-T LYMPHOBLASTIC LEUKEMIA: A SINGLE CENTRE EXPERIENCE FROM EASTERN INDIA |
PRATEEK DAS |
BHC-48 |
E |
06:30 PM - 06:38 PM |
IDENTIFICATION OF PARVOVIRUS B19 INFECTION IN PAEDIATRIC ACUTE LYMPHOBLASTIC LEUKAEMIA PATIENTS UNDERGOING CHEMOTHERAPY. |
AMIT NISAL |
BHC-50 |
E |
06:38 PM - 06:46 PM |
OUTCOME ASSESSMENT OF PHENOTYPE MATCHED PACKED RED BLOOD CELL (PRBC) TRANSFUSION IN THALASSEMIA PATIENTS, IN RELATION TO ALLOANTIBODY, AUTOANTIBODY FORMATION AND TRANSFUSION REQUIREMENT |
CHIRASREE SANYAL |
BHC-52 |
E |
06:46 PM - 06:54 PM |
HIGH-DOSE DEXAMETHASONE WITH ROMIPLOSTIM AS FRONTLINE THERAPY IN ACUTELY PRESENTING ITP: A STEP FORWARD IN ENHANCING RESPONSE RATES AND QUALITY OF LIFE |
TUSHAR PANDEY |
BHC-53 |
E |
06:54 PM - 07:02 PM |
CLINICAL PROFILE AND LABORATORY PARAMETERS OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA |
DIVIYA N |
BHC-54 |
E |
07:02 PM - 07:10 PM |
RARE BUT REAL; INSIGHTS INTO A CASE SERIES ON SHWACHMAN DIAMOND SYNDROME |
MINAL SONEJI |
BHC-56 |
E |
07:10 PM - 07:18 PM |
COMPARISONS OF RETICULOCYTE PARAMETERS BETWEEN NEONATES OF GESTATIONAL DIABETIC MOTHERS AND HEALTHY NEONATES BORN TO MOTHERS WITH UNCOMPLICATED PREGNANCY |
PRIYADARSHI PATTNAIK |
BHC-58 |
E |
07:18 PM - 07:26 PM |
OPTIMIZING LARGE LANGUAGE MODELS FOR CLINICAL DECISION SUPPORT IN HEMATOLOGY: A COMPARATIVE STUDY OF CUSTOMIZATION APPROACHES |
ROUNAK DUBEY |
BHC-59 |
E |
07:26 PM - 07:34 PM |
A STUDY OF ENDOCRINOLOGICAL DYSFUNCTION IN TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS WITH IRON OVERLOAD |
UDAY YANAMANDRA |
BHC-60 |
E |
07:34 PM - 07:42 PM |
IMPACT OF HEMOGLOBIN CONTENT ON POST-TRANSFUSION OUTCOMES IN ADULT HEMATO-ONCOLOGICAL PATIENTS |
VILASINI PATIL |
BHC-61 |
E |
07:42 PM - 07:50 PM |
CHALLENGES IN MANAGING HEMATOLOGICAL MALIGNANCIES WITH TUBERCULOSIS: A SINGLE-CENTER STUDY |
NAQASH SUSE |
BHC-62 |
E |
07:50 PM - 07:58 PM |
A DIAGNOSTIC PREDICTIVE MODEL FOR MACROTHROMBOCYTOPENIA |
VIJAY KUMAR CHAUDHARY |
BHC-64 |
E |
07:58 PM - 08:06 PM |
INSIGHTS INTO DIAMOND BLACKFAN ANEMIA PATHOPHYSIOLOGY IN INDIAN PATIENTS WITH RPL5 AND RPL35A GENE DELETIONS |
PRACHI SUNIL KAMBLE |
BHC-65 |
E |
08:06 PM - 08:14 PM |
EFFICACY OF DAILY VERSUS ALTERNATE DAY ORAL IRON THERAPY IN NEWLY DIAGNOSED IRON DEFICIENCY ANAEMIA |
SUDIP ROY |